ATE554793T1 - Konjugat - Google Patents

Konjugat

Info

Publication number
ATE554793T1
ATE554793T1 AT02755200T AT02755200T ATE554793T1 AT E554793 T1 ATE554793 T1 AT E554793T1 AT 02755200 T AT02755200 T AT 02755200T AT 02755200 T AT02755200 T AT 02755200T AT E554793 T1 ATE554793 T1 AT E554793T1
Authority
AT
Austria
Prior art keywords
polypeptide
moieties
therapeutic
expression vector
polynucleotide sequence
Prior art date
Application number
AT02755200T
Other languages
English (en)
Inventor
Mahendra Persaud Deonarain
Simon Stafford
Original Assignee
Photobiotics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Photobiotics Ltd filed Critical Photobiotics Ltd
Application granted granted Critical
Publication of ATE554793T1 publication Critical patent/ATE554793T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0071PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/009Neutron capture therapy, e.g. using uranium or non-boron material
    • A61K41/0095Boron neutron capture therapy, i.e. BNCT, e.g. using boronated porphyrins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT02755200T 2001-08-16 2002-08-16 Konjugat ATE554793T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0120022.9A GB0120022D0 (en) 2001-08-16 2001-08-16 Conjugate
PCT/GB2002/003813 WO2003015825A2 (en) 2001-08-16 2002-08-16 Conjugate

Publications (1)

Publication Number Publication Date
ATE554793T1 true ATE554793T1 (de) 2012-05-15

Family

ID=9920536

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02755200T ATE554793T1 (de) 2001-08-16 2002-08-16 Konjugat

Country Status (8)

Country Link
US (1) US7655753B2 (de)
EP (1) EP1416970B1 (de)
JP (1) JP2005501853A (de)
AT (1) ATE554793T1 (de)
AU (1) AU2002321496B2 (de)
CA (1) CA2456149A1 (de)
GB (1) GB0120022D0 (de)
WO (1) WO2003015825A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0520436D0 (en) 2005-10-07 2005-11-16 Photobiotics Ltd Biological materials and uses thereof
WO2008153725A2 (en) 2007-05-25 2008-12-18 North Carolina State University Viral nanoparticle cell-targeted delivery platform
GB0904825D0 (en) 2009-03-20 2009-05-06 Photobiotics Ltd Biological materials and uses thereof
US20130266663A1 (en) 2010-04-30 2013-10-10 Arthur Brown Sox9 inhibitors
US9095624B2 (en) 2011-05-23 2015-08-04 Contango Partners Group, Inc. Modular transport platform for targeted delivery of therapeutic agents
GB201416960D0 (en) * 2014-09-25 2014-11-12 Antikor Biopharma Ltd Biological materials and uses thereof
JP7399876B2 (ja) * 2018-04-16 2023-12-18 ジョージア テック リサーチ コーポレーション 病態治療のためのRNAエディターのmRNA駆動型発現
JP2022086791A (ja) * 2020-11-30 2022-06-09 大日本印刷株式会社 抗ウイルス性粘着シート

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4671958A (en) * 1982-03-09 1987-06-09 Cytogen Corporation Antibody conjugates for the delivery of compounds to target sites
US5851527A (en) * 1988-04-18 1998-12-22 Immunomedics, Inc. Method for antibody targeting of therapeutic agents
US5135736A (en) * 1988-08-15 1992-08-04 Neorx Corporation Covalently-linked complexes and methods for enhanced cytotoxicity and imaging
NZ244306A (en) 1991-09-30 1995-07-26 Boehringer Ingelheim Int Composition for introducing nucleic acid complexes into eucaryotic cells, complex containing nucleic acid and endosomolytic agent, peptide with endosomolytic domain and nucleic acid binding domain and preparation
US5837533A (en) 1994-09-28 1998-11-17 American Home Products Corporation Complexes comprising a nucleic acid bound to a cationic polyamine having an endosome disruption agent
RU2066552C1 (ru) * 1996-02-12 1996-09-20 Товарищество с ограниченной ответственностью "Био Прогресс" Композиция для фотодинамического повреждения клеток-мишеней и способ фотодинамического повреждения клеток-мишеней
DE19605548A1 (de) * 1996-02-15 1997-09-04 Boehringer Ingelheim Int Zusammensetzung für die Transfektion höherer eukaryotischer Zellen
US6462070B1 (en) * 1997-03-06 2002-10-08 The General Hospital Corporation Photosensitizer conjugates for pathogen targeting
US20020137901A1 (en) * 2001-01-22 2002-09-26 Cavanaugh Philip Gerard Synthesis, and photodynamic therapy-mediated anti-cancer, and other uses of chlorin e6-transferrin
US20020127224A1 (en) * 2001-03-02 2002-09-12 James Chen Use of photoluminescent nanoparticles for photodynamic therapy

Also Published As

Publication number Publication date
EP1416970A2 (de) 2004-05-12
GB0120022D0 (en) 2001-10-10
US7655753B2 (en) 2010-02-02
WO2003015825A3 (en) 2003-07-31
US20050234222A1 (en) 2005-10-20
JP2005501853A (ja) 2005-01-20
EP1416970B1 (de) 2012-04-25
WO2003015825A2 (en) 2003-02-27
AU2002321496B2 (en) 2008-05-29
CA2456149A1 (en) 2003-02-27

Similar Documents

Publication Publication Date Title
AR027391A1 (es) Composiciones farmaceuticas de toxina botulinica
BR0008688A (pt) Antagonistas de il-18 recombinantes utilizáveis no tratamento de distúrbios mediados por il-18
DK0910647T3 (da) Human DNase i hyperaktive varianter
EA201100072A1 (ru) Новые композиции и способы
EA201100070A1 (ru) Туберкулезный белок rv2386c, композиции и их применения
PL2054431T3 (pl) Konformery adhezyn bakteryjnych
ATE364595T1 (de) Pyridoxin- und pyridoxalanaloga als cardiovasculäre therapeutika
TR200003347T2 (tr) Neisseria meningitidis'denBASB029 polinükleotidleri ve polipeptidler
ATE554793T1 (de) Konjugat
WO2008040190A8 (fr) Petits peptides pour anti-angiogenèse et utilisation de ceux-ci
BRPI0409865A (pt) injeção intravenosa de ativadores de plasminogênio não neurotóxicos para o tratamento do ataque de apoplexia
BR0009170A (pt) ácidos nucléicos akt, polipeptìdeos e uso dos mesmos
DE602006020562D1 (de) Hren dafür
LT2002070A (en) Polynucleotide encoding rg1 polypeptide
JP2004513615A5 (de)
DE60036469D1 (de) 17867, eine menschliche aminopeptidase
SE9904289D0 (sv) Method and camposition for the treatment of adenovairal ocular infections
IL193310A0 (en) Antibody directed against a polypeptide that interacts with parkin and pharmaceutical compositions comprising the same
TR199902866T2 (xx) Organo- koruyucu aktiviteye sahip yeni BPC peptid tuzlar�, haz�rlanmalar� ve terapide kullan�lmalar� i�in prosesler.
DE60303149D1 (de) Salz von morphin-6-glucuronid
DK1156795T3 (da) Anvendelse af ravsyre eller salte deraf, og fremgangsmåde til behandling af insulinresistens
BR0015170A (pt) Proteìnas de hcv com oxirredução reversìvel e conformação similar à nativa
DK0811068T3 (da) Humane DNase I varianter
ATE313628T1 (de) Klonierung und expression von haemophilus somnus transferrin-bindenden proteinen
ATE287716T1 (de) Metallsalze als antimykotika